Earnings Ahead

HROW - Harrow Health, Inc.

17.37 -0.64 -3.55

Harrow Health, Inc.

Harrow Health, Inc.

About

Profile


Headquarters

California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HROW



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Harrow Health Non-GAAP EPS of $0.07, revenue of $20.3M misses by $1.43M
  • Harrow Health drops on new short report from Bonitas Research (update)
  • Novartis in pact with Harrow Health to sell U.S. rights for eyecare products
  • Harrow Health prices $25M stock offering
  • Harrow and iOR Partners expand national product supply deal
  • Harrow Health GAAP EPS of -$0.24 misses by $0.23, revenue of $22.8M misses by $0.34M
  • Harrow sells non‑ophthalmic compounding business, terms undisclosed
  • Harrow Health gains as subsidiary launches topical antibiotic
  • Harrow Health soars ~27% on FDA nod of anesthesia gel for the surface of the eye
  • Harrow Health Q2 Non-GAAP EPS down Y/Y, revenue up
  • Harrow Health files for $300M mixed shelf offering
  • Harrow Health Non-GAAP EPS of $0.03 beats by $0.07, revenue of $22.12M beats by $2.64M
  • Harrow Health GAAP EPS of -$0.27 misses by $0.23, revenue of $20.2M beats by $0.84M
  • Harrow Health eye anesthesia AMP-100 accepted for review by US FDA
  • EyePoint, ImprimisRx expand commercial alliance for Dexycu eye corticosteroid
  • Harrow Health EPS misses by $0.28, beats on revenue
  • Harrow Health acquires ophthalmic surgical drug candidate from Wakamoto Pharma
  • Harrow Health EPS misses by $0.10, beats on revenue
  • Harrow Health acquires patented ophthalmic surgical drug candidate from Sintetica
  • NovaBay partners with Imprimisrx to promote prescription Avenova
Date Price Open High Low Vol Change ER
Mar 10 7.070 7.100
7.200
6.930
75.75K -0.42%
Mar 9 7.100 7.240
7.530
7.100
47.65K -1.11%
Mar 8 7.180 7.080
7.250
6.979
85.82K 1.70%
Mar 7 7.060 7.370
7.578
7.000
70.86K -6.74%
Mar 4 7.570 7.560
7.620
7.260
27.36K 0.53%
 
Mar 3 7.530 7.790
7.850
7.360
31.81K -2.96%
Mar 2 7.760 7.710
7.780
7.540
64.74K 2.11%
Mar 1 7.600 7.760
7.940
7.600
45.05K -1.43%
Feb 28 7.710 7.690
7.940
7.671
74.28K 0%
Feb 25 7.710 7.990
8.005
7.620
60.35K -3.02%
Feb 24 7.950 8.030
8.060
7.701
97.54K -1.12%
Feb 23 8.040 8.410
8.517
7.980
93.28K -3.02%
Feb 22 8.290 7.920
8.550
7.800
109.68K 5.34%
Feb 18 7.870 8.010
8.460
7.860
58.41K -2.24%
Feb 17 8.050 8.020
8.170
7.850
32.53K -1.11%
Feb 16 8.140 8.128
8.382
8.010
37.49K -2.05%
Feb 15 8.310 8.140
8.340
8.075
32.84K 2.21%
Feb 14 8.130 8.200
8.410
8.030
23.29K -0.25%
Feb 11 8.150 8.280
8.460
8.050
44.77K -1.21%